Last $68.66 USD
Change Today +1.86 / 2.78%
Volume 2.6M
ISIS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - isis pharmaceuticals inc (ISIS)

Name (Connections)Board RelationshipsTitleKey Developments
Joseph Wender 137 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating, Governance & Review Committee and Member of Compensation Committee 
Joseph Klein III 14 RelationshipsDirector and Member of Audit Committee 
Breaux Castleman 23 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - isis pharmaceuticals inc (ISIS)

Name (Connections)Board RelationshipsTitle
Spencer Berthelsen M.D. 7 RelationshipsDirector, Chairman of Compensation Committee, Chairman of Nominating, Governance & Review Committee and Member of Science/Medical Committee
Joseph Wender 137 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating, Governance & Review Committee and Member of Compensation Committee
ISIS Compensation vs. Industry
768.3K
319.5K
Chief Executive Officer
377.9K
234.7K
Chief Financial Officer
664.0K
293.9K
Chief Operating Officer
Share price activity for ISIS PHARMACEUTICALS INC (ISIS)
52 Week Price Performance
ISIS
Industry Average

Nominating Committee* - isis pharmaceuticals inc (ISIS)

Name (Connections)Board RelationshipsTitleKey Developments
Joseph Wender 137 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating, Governance & Review Committee and Member of Compensation CommitteeIsis Pharmaceuticals, Inc. Appoints Sarah Boyce as Chief Business Officer
01/5/15
Spencer Berthelsen M.D. 7 RelationshipsDirector, Chairman of Compensation Committee, Chairman of Nominating, Governance & Review Committee and Member of Science/Medical CommitteeIsis Pharmaceuticals, Inc. Names Joseph Loscalzo to the Board of Directors
02/3/14

Corporate Governance Committee* - isis pharmaceuticals inc (ISIS)

Name (Connections)Board RelationshipsTitle
Spencer Berthelsen M.D. 7 RelationshipsDirector, Chairman of Compensation Committee, Chairman of Nominating, Governance & Review Committee and Member of Science/Medical Committee
Joseph Wender 137 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating, Governance & Review Committee and Member of Compensation Committee
ISIS and Competitor
Insiders vs. External
Board
25%
75%
Isis Pharmaceuticals, Inc.
5%
95%
Acorda Therapeutics, Inc.
14%
86%
DepoMed Inc.
8%
92%
ACADIA Pharmaceuticals Inc.
13%
87%
Tekmira Pharmaceuticals Corporation
8%
92%
Regulus Therapeutics Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISIS:US $68.66 USD +1.86

ISIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $38.14 USD -0.09
Acorda Therapeutics Inc $35.20 USD +0.19
Depomed Inc $22.99 USD -0.07
Regulus Therapeutics Inc $18.29 USD -0.28
Tekmira Pharmaceuticals Corp C$22.76 CAD +0.31
View Industry Companies
 

Industry Analysis

ISIS

Industry Average

Valuation ISIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 36.9x
Price/Book 30.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 31.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.